{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T05:34:53Z","timestamp":1782538493781,"version":"3.54.5"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CDTCNSND"],"published-print":{"date-parts":[[2005,10,1]]},"DOI":"10.2174\/156800705774322111","type":"journal-article","created":{"date-parts":[[2005,9,28]],"date-time":"2005-09-28T20:49:59Z","timestamp":1127940599000},"page":"507-530","source":"Crossref","is-referenced-by-count":106,"title":["Cannabinoids"],"prefix":"10.2174","volume":"4","author":[{"given":"Franjo","family":"Grotenhermen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Drug Target -CNS & Neurological Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/90804","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T10:02:01Z","timestamp":1448272921000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1568-007X&volume=4&issue=5&spage=507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,1]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/156800705774322111","relation":{},"ISSN":["1568-007X"],"issn-type":[{"value":"1568-007X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10,1]]}}}